NCT03355976 2025-10-09BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell CarcinomasBrown UniversityPhase 2 Active not recruiting46 enrolled
NCT03241745 2024-12-27A Study of Nivolumab in Selected Uterine Cancer PatientsMemorial Sloan Kettering Cancer CenterPhase 2 Completed35 enrolled 8 charts